NCT02669745View on ClinicalTrials.gov

The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

May 31, 2019

Study Completion Date

May 31, 2019

Conditions
Chinese
Trial Locations (1)

10032

Columbia University Medical Center, New York

Sponsors

Lead Sponsor

Agendia
All Listed Sponsors
lead

Agendia

INDUSTRY

NCT02669745 - The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients | Biotech Hunter | Biotech Hunter